Groupe Bruxelles Lambert raised Recordati bid: GBL stock gains 1.21 percent
Published on 10/12/2026 at 10:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Groupe Bruxelles Lambert raised its Recordati offer to EUR 53.00 per share from EUR 51.29 on October 6, 2026.
- The Recordati acceptance period runs to October 23, 2026, while GBL's next earnings date is November 4, 2026.
- GBL stock was at EUR 69.58 at Lang & Schwarz on October 12, 2026, 1.21 percent above the October 9 Xetra close of EUR 68.75.
- GBL reported EUR 653.1 million of share capital and 129.8 million shares as of June 30, 2026.
Groupe Bruxelles Lambert (BE0003797140) raised its Recordati takeover offer from EUR 51.29 to EUR 53.00 per share on October 6, 2026, while GBL stock was trading at EUR 69.58 at Lang & Schwarz on October 12, 2026. The price stood 1.21 percent above the Xetra close of October 9, 2026, at EUR 68.75.
Recordati offer reaches EUR 53.00
According to Il Sole 24 ORE on October 6, 2026, the revised cash offer is intended to delist the Italian pharmaceutical group. The acceptance period was extended from October 15 to October 23, and payment for the new consideration is scheduled for November 2, 2026.
The revised EUR 53.00 offer is 3.33 percent above the previous EUR 51.29 proposal. The bidder described the new consideration as its best and final offer, making the acceptance rate and the October 23 deadline the immediate transaction milestones.
Three milestones shape the story
As of June 30, 2026, GBL reported EUR 653.1 million of share capital represented by 129.8 million shares. The company also held 10,288,252 of its own shares, equal to 7.93 percent of issued capital.
On August 25, 2026, GBL issued a EUR 500 million bond, according to MarketScreener. The financing event and the Recordati bid show how the investment holding company is combining portfolio activity with transaction funding.
What does the bid mean for GBL?
GBL's portfolio value was EUR 12.8 billion at the end of 2025, with listed assets representing 54.3 percent and direct private assets 32.2 percent, according to MarketScreener. That mix gives the Recordati transaction a measurable place within a portfolio that spans listed and private holdings.
Upcoming dates for shareholders
The next dated transaction milestone is October 23, 2026, when the Recordati acceptance period ends. MarketScreener lists November 4, 2026, for GBL's third-quarter earnings release.
Stock holds above EUR 68.75
GBL stock was trading at EUR 69.58 at Lang & Schwarz on October 12, 2026 at 10:09 a.m. CEST, up 1.21 percent versus the Xetra close of October 9, 2026, at EUR 68.75. The 52-week range was EUR 67.90 to EUR 85.65, while market capitalization stood at EUR 8.3 billion on October 12, 2026.
The further course of trading is shown by the continuously updated real-time quote of GBL stock.
Groupe Bruxelles Lambert stock facts
- Company: Groupe Bruxelles Lambert S.A.
- ISIN: BE0003797140
- Ticker: GBLB
- Primary exchange: Euronext Brussels
- Price Lang & Schwarz as of October 12, 2026, 10:09 a.m. CEST: EUR 69.58
- Change versus Xetra close: plus 1.21 percent
- Xetra close October 9, 2026: EUR 68.75
- Market capitalization: EUR 8.3 billion (as of October 12, 2026)
- 52-week range: EUR 67.90-EUR 85.65
- Sector / Industry: Financials / Investment Holding Companies
- Index membership: BEL 20
- Next earnings date: November 4, 2026
Market context: Latest market reports.
